IPI Terminal - Patent Intelligence Platform
IPI Terminal - Patent Intelligence Platform
DashboardSearchScreenerDaily ReportNewsInvestor IntelligenceMy Profile

Information

AboutTeamHow to UseIP GlossaryData SourcesContactSupport
Plans & Services
Sign InCreate Free Account
IPI Terminal - Patent Intelligence Platform
DashboardSearchScreenerDaily ReportNewsInvestor IntelligenceMy Profile

Information

AboutTeamHow to UseIP GlossaryData SourcesContactSupport
Plans & Services
Sign InCreate Free Account
Have a patent not listed?SUBMIT MY PATENT
AboutData SourcesContact|Terms of ServicePrivacy PolicyCookie PolicyCookie Settings

IPI Terminal is operated by Human IP SARL (Switzerland). Not legal, financial, or investment advice.

v1.5.8

Full Legal Disclaimer

IPI Terminal is an intellectual property analytics and patent intelligence platform. Patent information, valuations, commercialization metrics, and analytical outputs are provided solely for informational and research purposes and do not constitute legal, financial, investment, tax, accounting, or other professional advice. Nothing on this platform constitutes an offer to sell, solicitation of an offer to buy, or recommendation regarding any security, digital asset, token, intellectual property interest, or financial instrument.

All News

Patent of the Week

Our flagship weekly feature. Each edition spotlights a single patent with standout growth potential, examining its market opportunity, innovation strength, and what it signals for IP investors.

Latest EditionSep 4, 2026

Patent of the Week: IBM Advances ReRAM with Novel Resistive Switching Memory Cell

International Business Machines Corp strengthens its position in next-generation memory technologies with a sophisticated resistive switching device

US11502252B2 presents a weighted advancement in resistive random access memory (ReRAM) technology featuring a high work function metal core for enhanced performance at the nanoscale. This invention by IBM holds significant promise in the evolving landscape of high-density memory and neuromorphic computing applications.

Read the full feature

Past Editions

Aug 28, 2026

Patent of the Week: Compositions Targeting Tumor-Associated Macrophages for Cancer and Inflammatory Diseases

Sanford Burnham Prebys Medical Discovery Institute's patent US11571484B2 demonstrates innovation in bioengineering peptides that target tumor-associated macrophages. This technology spans both diagnostic and therapeutic applications in cancer and inflammatory disorders, signaling strategic importance within the healthtech domain despite development and market challenges.

Aug 25, 2026

Patent of the Week: Patient Risk Assessment Based on Data from Multiple Sources in a Healthcare Facility

Hill Rom Services Inc has developed a healthcare analytics apparatus that aggregates data from multiple patient support devices to produce risk scores related to sepsis, falls, and pressure injuries. This patent highlights a strategic advancement in patient safety and operational efficiency within healthcare facilities. Its high citation volume and strong HIS score underline its significance in the healthtech domain.

Aug 25, 2026

Patent of the Week: Patient Risk Assessment Based on Data from Multiple Sources

Hill Rom Services Inc's patent US11504071B2 introduces an apparatus that aggregates data from multiple medical devices to generate real-time risk assessments for sepsis, falls, and pressure injuries. This innovation reflects a growing trend in healthtech toward data fusion and clinical decision support systems that address patient safety and operational efficiency in healthcare facilities.

Aug 12, 2026

Patent of the Week: Toyota’s Advanced Fuel Cell System for Optimized Pressure Control

Toyota Motor Corp’s patent US11569516B2 outlines a refined fuel cell system that dynamically manages pressure to optimize performance during load fluctuations. This development reinforces Toyota’s leadership in fuel cell technology with strong commercial and sustainable energy implications.

Aug 11, 2026

Patent of the Week: Polyglutamated Antifolates and Their Therapeutic Delivery

LEAF Holdings Group LLC's patent on polyglutamated antifolates encapsulated in liposomes presents a novel approach to treating hyperproliferative and immune disorders. With a significant citation count and a strong technical foundation, this patent highlights strategic value in the HEALTHTECH sector.

Jul 27, 2026

Patent of the Week: HMGB1 Antagonist Treatment Advances Sepsis Care

US11524048B2 represents a significant advancement in sepsis therapy using proteolysis targeting chimera technology for selective degradation of the HMGB1 protein. The Feinstein Institutes for Medical Research holds this high-impact patent, signaling promising commercial and licensing potential in the burgeoning biopharma landscape.

Jul 14, 2026

Patent of the Week: Attention-based sequence transduction neural networks reshape AI

US10452978B2, assigned to Google LLC, covers pioneering attention-based neural network architectures that have transformed sequence transduction in AI. This foundational technology drives breakthroughs in NLP and speech recognition, establishing a high-value asset with broad commercial and licensing potential.

Jun 28, 2026

Patent of the Week: Method and apparatus for pulse gas delivery with concentration measurement

MKS Instruments quietly owns the plumbing of modern chipmaking. This week we break down a precision gas-delivery patent that sits at the heart of advanced semiconductor fabrication, and why IP investors should be paying attention as AI chip demand accelerates.